What's Behind the Volpara-ScreenPoint Partnership?
Volpara Solutions Chief Knowledge Officer Julian Marshall talks with Diagnostic Imaging about the impetus and impact of the partnership with ScreenPoint Medical
During the Radiological Society of North America 2019 annual meeting Diagnostic Imaging sat down with Julian Marshall, chief knowledge officer for breast imaging analytics company Volpara Solutions, to discuss the growing partnership with image analysis developer ScreenPoint Medical. This partnership brings ScreenPoint's artificial intelligence-based detection and decision support software to Volpara customers.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Shows Benefits of AI in Detecting Lung Cancer Risk in Non-Smokers
November 22nd 2023Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
Could an Emerging AI System Lead to Earlier Autism Detection with DT-MRI?
November 21st 2023Through assessment of diffusion tensor MRI of the brain, a new AI system reportedly offers a 97 percent sensitivity rate in diagnosing autism in children between two to four years of age, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
